Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Clinical trial NCT01401959 · COMPLETED
Trial details
- NCT number
- NCT01401959
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-23
- Primary completion
- 2017-04-03
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.